Verification register Bio, Health & Neuro
Current reading
The readiness gap, in one scan
AI-assisted assembly · derived results
- Claimed
- 80
- Reported
- 74
- Verified
- 65
- Gap
- +15
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed minus verified
Evidence strength Growing
Decision
What the current evidence supports
Human editorial judgment · 2026-06-28
Proceed with caution
- Why
- It is a freshly GA, vendor-backed end-to-end product with strong throughput claims (sequencing-based, single-cell, 2x genes vs panels), but fresh-frozen-only scope, Illumina-stack lock-in, higher sequencing/compute cost, and no independent validation limit near-term applicability.
- Next
- Pilot only if a fresh-frozen spatial-transcriptomics use case and a NovaSeq/NextSeq instrument are already in place; otherwise wait for the 2027 FFPE version and the first independent gene-detection benchmarks vs 10x/NanoString.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 7
- Tier 1
- 0
- Tier 2
- 3
- Tier 3
- 4
- Supports
- 3
- Contradicts
- 2
- Context
- 2
- Latest observed
- 2026-06-08
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
This is the initial public reading. No earlier readiness change is recorded.